Meanwhile, NRP1 was recently shown to have an immune suppressive role in CD4+ T cells and regulatory T cells in immune diseases and tumor immunity (Solomon et al., 2011; Kumanogoh and Kikutani, 2013; Overacre-Delgoffe et al., 2017). Here, CD4 is linked to neoplasm.